Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3016% below fair value
$103.32+1.23 (+1.20%)
Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%
Zimmer Biomet revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Zimmer Biomet's revenue for the twelve months ending Jun 30, 2026 was $8.51B, up 8.6% year over year. For fiscal 2025 it was $8.23B, up 7.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $8.23B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.23B | +7.2% |
| FY2024 | Dec 31, 2024 | $7.68B | +3.8% |
| FY2023 | Dec 31, 2023 | $7.39B | +6.5% |
| FY2022 | Dec 31, 2022 | $6.94B | +1.6% |
| FY2021 | Dec 31, 2021 | $6.83B | +11.4% |
| FY2020 | Dec 31, 2020 | $6.13B | -23.2% |
| FY2019 | Dec 31, 2019 | $7.98B | +0.6% |
| FY2018 | Dec 31, 2018 | $7.93B | +1.7% |
| FY2017 | Dec 31, 2017 | $7.80B | +1.8% |
| FY2016 | Dec 31, 2016 | $7.67B | +27.9% |
| FY2015 | Dec 31, 2015 | $6.00B | +28.3% |
| FY2014 | Dec 31, 2014 | $4.67B | +1.1% |
| FY2013 | Dec 31, 2013 | $4.62B | +3.4% |
| FY2012 | Dec 31, 2012 | $4.47B | +0.4% |
| FY2011 | Dec 31, 2011 | $4.45B | +5.5% |
| FY2010 | Dec 31, 2010 | $4.22B | +3.0% |
| FY2009 | Dec 31, 2009 | $4.10B | -0.6% |
| FY2008 | Dec 31, 2008 | $4.12B | +5.7% |
| FY2007 | Dec 31, 2007 | $3.90B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.18B | +4.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.09B | +9.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.24B | +10.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.00B | +9.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.08B | +7.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.91B | +1.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | +4.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.82B | +4.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.94B | +3.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.89B | +3.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.94B | +6.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.75B | +5.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.87B | +4.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.83B | +10.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.83B | +2.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.67B | -0.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.78B | +1.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.66B | +3.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.78B | -14.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.69B | -12.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.76B | +43.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.60B | -10.2% |
| Q4 FY2020 | Dec 31, 2020 | $2.09B | -1.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.93B | +1.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.23B | -38.3% |
| Q1 FY2020 | Mar 31, 2020 | $1.78B | -9.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.13B | +2.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.89B | +3.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.99B | -0.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.98B | -2.1% |
| Q4 FY2018 | Dec 31, 2018 | $2.07B | +0.1% |
| Q3 FY2018 | Sep 30, 2018 | $1.84B | +1.3% |
| Q2 FY2018 | Jun 30, 2018 | $2.01B | +3.0% |
| Q1 FY2018 | Mar 31, 2018 | $2.02B | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | $2.07B | +2.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.81B | -1.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.95B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.97B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.01B | – |
| Q3 FY2016 | Sep 30, 2016 | $1.83B | – |
See a number that looks wrong?